Bausch + Lomb and CROMA donated 50,000 Yellox (bromfenac sodium sesquihydrate, an effective, non-steroidal anti-inflammatory drug (NSAID) for postoperative ocular inflammation following cataract extraction, to Light for the World projects in Africa, according to a B+L spokesperson. These eye drops are vital for post-operative treatment of cataract patients. Some 39 million people worldwide are blind; the top cause for blindness is due to cataract (51%, making cataract the leading cause of blindness globally). Cataract is the clouding of the human eye´s crystalline lens. This is despite cataract surgery being one of the most common surgical procedures worldwide. For many, poverty makes accessing even basic eye care impossible. The Austrian organization Light for the World, part of an European confederation of national development NGOs, supports people who have no access to ophthalmic care. Through cataract surgeries performed in 148 different projects in Africa, Asia, Latin America and Southeast Europe, Light for the World saved the sight of 42,500 people in 2012.